Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment

被引:8
|
作者
Pinotti, Caitlan S. [1 ]
Cannon, Laura [2 ]
Dvergsten, Jeffrey A. [1 ]
Wu, Eveline Y. [2 ,3 ]
机构
[1] Duke Univ, Dept Pediat, Div Pediat Rheumatol, Durham, NC 27708 USA
[2] Univ N Carolina, Dept Pediat, Div Pediat Rheumatol, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Dept Pediat, Div Pediat Allergy & Immunol, Chapel Hill, NC USA
关键词
juvenile dermatomyositis; calcinosis; myositis-specific antibody; pathogenesis; treatment; INFLAMMATORY MYOPATHIES; MYOSITIS; DISEASE; AUTOANTIBODIES; RECALCITRANT; FEATURES; CHILDREN;
D O I
10.3389/fmed.2023.1155839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcinosis, or the deposition of insoluble calcium salts in the skin, subcutaneous tissue, fascia, tendons, and muscles, is a feared complication of juvenile dermatomyositis. Calcinosis is estimated to affect up to 40% of patients with juvenile dermatomyositis and contributes to significant disease morbidity. Calcinosis can be challenging to treat, and the most effective treatment remains unknown because of a lack of comparative studies. We aim to review the literature published in the last 5 years to summarize updates on the pathogenesis and treatment of calcinosis in juvenile dermatomyositis and describe future areas for research.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis
    Oliveri, MB
    Palermo, R
    Mautalen, C
    Hubscher, O
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (12) : 2152 - 2155
  • [22] High frequency of calcinosis in juvenile dermatomyositis: a risk factor study
    Clemente, Gleice
    Petry Piotto, Daniela Gerent
    Barbosa, Cassia
    Peracchi, Octavio Augusto
    Len, Claudio Arnaldo
    Esteves Hilario, Maria Odete
    Terreri, Maria Teresa R. A.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (04) : 545 - 553
  • [23] Update on the treatment of calcinosis in dermatomyositis
    Shinjo, Samuel Katsuyuki
    Carlos de Souza, Fernando Henrique
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (02) : 211 - 214
  • [24] Calcinosis in dermatomyositis
    Davuluri, Srijana
    Chung, Lorinda
    Lood, Christian
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (06) : 453 - 458
  • [25] An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem
    Ichiki, Y
    Akiyama, T
    Shimozawa, N
    Suzuki, Y
    Kondo, N
    Kitajima, Y
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 894 - 897
  • [26] Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
    Amir B. Orandi
    Vikas R. Dharnidharka
    Noor Al-Hammadi
    Kevin W. Baszis
    Pediatric Rheumatology, 16
  • [27] Juvenile Dermatomyositis and Extensive Calcinosis. Treatment With Methylprednisolone and Methotrexate
    Morel Ayala, Zoilo
    Martinez Ramirez, Rogelio
    Mendieta Zeron, Samara
    Faugier Fuentes, Enrique
    Maldonado Velazquez, Rocio
    REUMATOLOGIA CLINICA, 2008, 4 (06): : 248 - 250
  • [28] Actuality of juvenile dermatomyositis
    Zouagui, Amine
    Abourazzak, Sana
    Lakhdar Idrissi, Mounia
    Zohra Souilmi, Fatima
    Chaouki, Sana
    Atmani, Samir
    Bouharrou, Abdelhak
    Hida, Moustapha
    JOINT BONE SPINE, 2011, 78 (03) : 235 - 240
  • [29] Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications
    Harel, L
    Harel, G
    Korenreich, L
    Straussberg, R
    Amir, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (05) : 1129 - 1132
  • [30] Effect of abatacept added to mycophenolate mofetil for refractory calcinosis in juvenile dermatomyositis
    Shimizu, Maho
    Nakaseko, Haruna
    Muro, Yoshinao
    Iwata, Naomi
    MODERN RHEUMATOLOGY CASE REPORTS, 2025,